Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Summary

1)Preliminarily evaluate the treatment effect of Icotinib Hydrochloride Tablets on NF2; 2)Preliminarily evaluate the safety and the patient's tolerance of the treatment of Icotinib; 3)Provide an objective basis for an enlarged randomized double-blind trial.

Timeline

Start

2016-07

Primary completion

2018-07

Completion

2018-07

Drugs

Indications